Authors
Reza Ghalehtaki, Alireza Shariati, Ehsan Mehrtabar, Mohammad Reza Arshadi, Taher Fanihagh
Published in
Critical reviews in oncology/hematology. Pages 105701. Nov 15, 2026. Epub Nov 15, 2026.
Abstract
Trimodality therapy is an established bladder-preserving alternative to radical cystectomy for muscle-invasive bladder cancer (MIBC), but recurrence remains common. Immune checkpoint inhibitors (ICIs) are active in urothelial carcinoma and may enhance radiotherapy-based bladder preservation. We conducted a systematic review and meta-analysis of the efficacy and safety of adding ICIs to curative-intent non-operative treatment for MIBC.
PubMed, Scopus, and Embase were searched through June 28, 2026. Eligible studies included adults with MIBC receiving bladder-preserving radiotherapy or chemoradiotherapy incorporating an ICI. The review followed PRISMA and was registered in PROSPERO. Outcomes included overall survival (OS), bladder-intact disease-free survival (BIDFS), clinical complete response (cCR), and treatment- and immune-related adverse events (trAEs, irAEs). Proportions were pooled using random-effects models with Hartung-Knapp adjustment.
Twelve studies comprising 335 patients were included. Pooled OS was 95%, 91%, 80%, and 73% at 6, 12, 24, and 36 months, respectively. Pooled BIDFS was 85% at 6 months and 66% at 24 months. Pooled cCR was 81%, rising to 85% in chemotherapy-containing studies. All-grade and grade ≥3 trAEs occurred in 94% and 36% of patients, while all-grade and grade ≥3 irAEs occurred in 70% and 17%. The evidence was limited by small sample sizes, heterogeneity, and predominantly noncomparative designs.
ICI-containing radiotherapy-based bladder preservation shows encouraging activity, but incremental benefit over standard therapy remains unproven. Randomized trials, including SWOG/NRG S1806 and KEYNOTE-992, are needed.
PMID:
43035127
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0